Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025)
Benitec Biopharma (BNTC) reported Change in Account Payables of $701000.0 for Q4 2025, down 46.16% on a YoY basis from $1.3 million in Q4 2024, and up 460.8% sequentially from $125000.0 in Q3 2025.
Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Change in Account Payables data on file, last reported at $701000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 46.16% year-over-year to $701000.0; the trailing twelve-month figure through Dec 2025 stood at -$2.5 million (down 1283.18% YoY), and the FY2025 full-year result was -$2.4 million, down 352.71% from the prior year.
- Change in Account Payables grew to $701000.0 in Q4 2025, from $125000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q1 2021 to a low of -$3.8 million in Q1 2025.
- A 5-year average of $115900.0 and a median of $533000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 376.95% in 2021 and slumped 466.51% in 2024, its largest moves.
- Tracing BNTC's Change in Account Payables over 5 years: stood at $853000.0 in 2021, then slumped by 164.48% to -$550000.0 in 2022, then surged by 307.45% to $1.1 million in 2023, then advanced by 14.11% to $1.3 million in 2024, then slumped by 46.16% to $701000.0 in 2025.
- Business Quant data shows BNTC's Change in Account Payables at $701000.0 in Q4 2025, $125000.0 in Q3 2025, and $484000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 701,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | -3.84 Mn |
| Mar 31, 2025 | -3.84 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | -322,000.00 |
| Sep 30, 2024 | -322,000.00 |
| Jun 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | -2.31 Mn |
| Mar 31, 2024 | -2.31 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 566,000.00 |
| Sep 30, 2023 | 566,000.00 |